article which permits unrestricted noncommercial use, provided the original work is properly cited. Virus Adaptation and Treatment 2012:4 51–63 Virus Adaptation and Treatment

Using a single tablet regimen of darunavir, cobicistat, emcitrabine, and tenofovir alafenamide in virally suppressed HIV-1 patients is an adequate treatment option for controlling HIV

Kathuria, Priya

October 2021

A clinical decision report using: Orkin C, Molina JM, Negredo E, et al. Efficacy and safety of switc...

The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase

Andrei, Graciela
Gillemot, Sarah
Topalis, Dimitrios
Snoeck, Robert

February 2018

Genital herpes is an important cofactor for acquisition of HIV infection and effective prophylaxis i...

Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV

Omeje I
Okwundu CI

January 2012

Geneeskunde en GesondheidswetenskappeSentrum vir Bewysgebaseerde GesonheidsorgPlease help us populat...

article which permits unrestricted noncommercial use, provided the original work is properly cited. Patient Preference and Adherence 2013:7 531–542 Patient Preference and Adherence

Claudia Bernardini
Franco Maggiolo
Correspondence Claudia Bernardini

August 2016

Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment ...

which permits unrestricted noncommercial use, provided the original work is properly cited. HIV/AIDS- Research and Palliative Care 2013:5 41–49

Palliative Care
Mark A Wainberg
Correspondence Mark
A Wainberg

August 2016

Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility...

in comparison with other antiretroviral drugs

Kathleen Ferrer
Natella Rakhmanina

September 2016

article which permits unrestricted noncommercial use, provided the original work is properly cited

Tenofovir: Once-daily Dosage in the Management of HIV Infection

A Marie James
Igho Ofotokun
I Sheth
Edward P. Acosta
Jennifer R. King

October 2015

ral ssBioMed CentJournal of the International AIDS Society Open AcceResearch article Effectiveness and Safety of Generic Fixed-Dose Combination of

Sanjay Pujari
Ameet Dravid
Nikhil Gupte
Kedar Joshix
Vivek Bele
Sanjay Pujari

August 2016

Objective: To assess effectiveness and safety of a generic fixed-dose combination of tenofovir (TDF)...

ImmunoTargets and Therapy 2013:2 1–10

Dylan Alston
Jerry D Brewer
Correspondence Jerry Brewer

September 2016

article which permits unrestricted noncommercial use, provided the original work is properly cited

© 2012 Iskandar et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. Journal of Multidisciplinary Healthcare 2012:5 329–336

Journal Of Multidisciplinary Healthcare
Teddy Hidayat
Ike Mp Siregar
Tri H Achmad
Reinout Van Crevel
Andre Van Der Ven
Padjadjaran Univervisity Nijmegen

August 2016

Successful testing and treating of HIV/AIDS in Indonesia depends on the addiction treatment modality...

Volume 2012, Article ID 105980, 6 pages doi:10.1155/2012/105980 Clinical Study Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults

Mohammed Lamorde Pauline Byakika-kibwika

October 2015

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults

Wissam K. Kabbara
Wijdan H. Ramadan

September 2015

Summary: This paper reviews the current literature and information on the combination drug Complera™...

CLINICAL SCIENCE Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1–Infected Patients

Edwin Dejesus
Louis Sloan
Douglas J. Ward
K John F. Flaherty
Ramin Ebrahimi

February 2015

Objective: To evaluate a simplification strategy for HIV-1–infected patients virologically suppresse...

Prep Adherence to Tenofovir-Based Therapeutics Seems Efficacious in Reducing HIV Infection Dissemination: A Comparative Evaluation on The Therapeutic Potency of Tenofovir-Based Prep & Dapivirine-Based Antiretroviral (ARV) Microbicide in HIV Prevention

Paria, Ananya

August 2019

This dissertation is being archived for campus access to current students and staff only at the requ...

Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population.

López-Cortés, Luis F
Viciana, Pompeyo
Girón-González, José A
Romero-Palacios, Alberto
Márquez-Solero, Manuel
Martinez-Perez, Maria A
López-Ruz, Miguel A
Torre-Lima, Javier de la
Téllez-Pérez, Francisco
Delgado-Fernández, Marcial
Garcia-Lázaro, Milagros
Lozano, Fernando
Mohamed-Balghata, Mohamed O

May 2014

Journal Article; ClinicalTrials.gov NCT01437241.Etravirine (ETV) is recommended in combination with ...

Using a single tablet regimen of darunavir, cobicistat, emcitrabine, and tenofovir alafenamide in virally suppressed HIV-1 patients is an adequate treatment option for controlling HIV

Kathuria, Priya

October 2021

A clinical decision report using: Orkin C, Molina JM, Negredo E, et al. Efficacy and safety of switc...

The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase

Andrei, Graciela
Gillemot, Sarah
Topalis, Dimitrios
Snoeck, Robert

February 2018

Genital herpes is an important cofactor for acquisition of HIV infection and effective prophylaxis i...

Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV

Omeje I
Okwundu CI

January 2012

Geneeskunde en GesondheidswetenskappeSentrum vir Bewysgebaseerde GesonheidsorgPlease help us populat...

article which permits unrestricted noncommercial use, provided the original work is properly cited. Patient Preference and Adherence 2013:7 531–542 Patient Preference and Adherence

Claudia Bernardini
Franco Maggiolo
Correspondence Claudia Bernardini

August 2016

Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment ...

which permits unrestricted noncommercial use, provided the original work is properly cited. HIV/AIDS- Research and Palliative Care 2013:5 41–49

Palliative Care
Mark A Wainberg
Correspondence Mark
A Wainberg

August 2016

Combination therapies, effectiveness, and adherence in patients with HIV infection: clinical utility...

in comparison with other antiretroviral drugs

Kathleen Ferrer
Natella Rakhmanina

September 2016

article which permits unrestricted noncommercial use, provided the original work is properly cited

Tenofovir: Once-daily Dosage in the Management of HIV Infection

A Marie James
Igho Ofotokun
I Sheth
Edward P. Acosta
Jennifer R. King

October 2015

ral ssBioMed CentJournal of the International AIDS Society Open AcceResearch article Effectiveness and Safety of Generic Fixed-Dose Combination of

Sanjay Pujari
Ameet Dravid
Nikhil Gupte
Kedar Joshix
Vivek Bele
Sanjay Pujari

August 2016

Objective: To assess effectiveness and safety of a generic fixed-dose combination of tenofovir (TDF)...

ImmunoTargets and Therapy 2013:2 1–10

Dylan Alston
Jerry D Brewer
Correspondence Jerry Brewer

September 2016

article which permits unrestricted noncommercial use, provided the original work is properly cited

© 2012 Iskandar et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. Journal of Multidisciplinary Healthcare 2012:5 329–336

Journal Of Multidisciplinary Healthcare
Teddy Hidayat
Ike Mp Siregar
Tri H Achmad
Reinout Van Crevel
Andre Van Der Ven
Padjadjaran Univervisity Nijmegen

August 2016

Successful testing and treating of HIV/AIDS in Indonesia depends on the addiction treatment modality...

Volume 2012, Article ID 105980, 6 pages doi:10.1155/2012/105980 Clinical Study Effect of Food on the Steady-State Pharmacokinetics of Tenofovir and Emtricitabine plus Efavirenz in Ugandan Adults

Mohammed Lamorde Pauline Byakika-kibwika

October 2015

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults

Wissam K. Kabbara
Wijdan H. Ramadan

September 2015

Summary: This paper reviews the current literature and information on the combination drug Complera™...

CLINICAL SCIENCE Simplification of Antiretroviral Therapy to a Single-Tablet Regimen Consisting of Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate Versus Unmodified Antiretroviral Therapy in Virologically Suppressed HIV-1–Infected Patients

Edwin Dejesus
Louis Sloan
Douglas J. Ward
K John F. Flaherty
Ramin Ebrahimi

February 2015

Objective: To evaluate a simplification strategy for HIV-1–infected patients virologically suppresse...

Prep Adherence to Tenofovir-Based Therapeutics Seems Efficacious in Reducing HIV Infection Dissemination: A Comparative Evaluation on The Therapeutic Potency of Tenofovir-Based Prep & Dapivirine-Based Antiretroviral (ARV) Microbicide in HIV Prevention

Paria, Ananya

August 2019

This dissertation is being archived for campus access to current students and staff only at the requ...

Clinical and Virological Efficacy of Etravirine Plus Two Active Nucleos(t)ide Analogs in an Heterogeneous HIV-Infected Population.

López-Cortés, Luis F
Viciana, Pompeyo
Girón-González, José A
Romero-Palacios, Alberto
Márquez-Solero, Manuel
Martinez-Perez, Maria A
López-Ruz, Miguel A
Torre-Lima, Javier de la
Téllez-Pérez, Francisco
Delgado-Fernández, Marcial
Garcia-Lázaro, Milagros
Lozano, Fernando
Mohamed-Balghata, Mohamed O

May 2014

Journal Article; ClinicalTrials.gov NCT01437241.Etravirine (ETV) is recommended in combination with ...

Using a single tablet regimen of darunavir, cobicistat, emcitrabine, and tenofovir alafenamide in virally suppressed HIV-1 patients is an adequate treatment option for controlling HIV

Kathuria, Priya

October 2021

A clinical decision report using: Orkin C, Molina JM, Negredo E, et al. Efficacy and safety of switc...

The anti-HIV drug tenofovir, a reverse transcriptase inhibitor, also targets the herpes simplex virus (HSV) DNA polymerase

Andrei, Graciela
Gillemot, Sarah
Topalis, Dimitrios
Snoeck, Robert

February 2018

Genital herpes is an important cofactor for acquisition of HIV infection and effective prophylaxis i...

Effectiveness and safety of first-line tenofovir + emtricitabine + efavirenz for patients with HIV

Omeje I
Okwundu CI

January 2012

Geneeskunde en GesondheidswetenskappeSentrum vir Bewysgebaseerde GesonheidsorgPlease help us populat...

article which permits unrestricted noncommercial use, provided the original work is properly cited. Virus Adaptation and Treatment 2012:4 51–63 Virus Adaptation and Treatment

Abstract

Extracted data

article which permits unrestricted noncommercial use, provided the original work is properly cited. Virus Adaptation and Treatment 2012:4 51–63 Virus Adaptation and Treatment

Abstract

Extracted data

Related items

Related items